samedan logo
 
 
 
spacer
home > ebr > autumn 2014 > testing times
PUBLICATIONS
European Biopharmaceutical Review

Testing Times

Mammalian cells are one of the most widely-used platforms in the production of biopharmaceuticals. Among them, Chinese hamster ovary (CHO) and human embryonic kidney (HEK 293) cells are extensively used for the production of recombinant proteins, vaccines and viral vectors.

In the manufacturing of biopharmaceuticals, the use of serum-free medium has grown significantly in industrial applications where the use of bovine serum represents a safety hazard, as well as a source of unwanted contamination. Furthermore, the use of non-animal-derived and chemicallydefined culture media has become more generally adopted. This is because culture media used for animal cell cultures is very complex. Historically, serum has been a crucial component of their composition as a provider of multifaceted biological molecules, such as hormones and growth factors, as well as numerous low molecular weight nutrients (1).

he emergence of industrial-scale mammalian cell culture for the production of protein pharmaceuticals has presented a new challenge for cell culture medium design, and quality control aspects have arisen from the use of foetal bovine serum (FBS). The issues of reliability of supply, variability in performance and the risk of biological contaminants (mycoplasmas and viruses) has created serious safety concerns among regulatory agencies. These are further increased by the emergence of prion-related diseases – specifically bovine spongiform encephalomyelitis. This has led to a rising use in chemically-defined nonanimal- sourced medium components to replace both serum and medium supplements purified from animal sources, such as insulin, transferrin and albumin (2-4).

Protein Types

Insulin serves as a growth and maintenance factor, and is considered to be important for serum-free cultures (5). It stimulates uridine, glucose uptake and synthesis of RNA, proteins and lipids, and also increases fatty acid and glycogen synthesis (6).

Transferrin is one of the most essential growth-promoting supplements in serum-free medium, and its omission causes severe inhibition of cell growth (7). It is an iron-binding glycoprotein that interacts with surface receptors and is closely related to the transport of iron across the plasma membrane (8). Transferrin also has additional in vitro functions – for example, chelation of deleterious trace materials that are unlikely to be replaced by other components.

Selenium is a trace element essential for mammalian cell cultures (9). Its mechanism is poorly understood, although there is evidence that selenium enhances growth rate in serum-free cultures (10). Lipids are required for proliferation, differentiation and antibody secretion. They play a major role in the cell membrane, which is composed of a phospholipid bilayer, and help in the transmission of nutrients into the cell and excretion of proteins out of the cell (11).

Albumin – most commonly known as human serum albumin – prevents the toxic effect of free fatty acids on cells in culture, acts as a metal ion binding protein, and has antioxidant effects (12).

Design of Experiments

The optimisation of the media composition – in terms of selecting the most appropriate components, as well as their ideal concentration – can be performed using design of experiments (DoE). DoE is a useful method that allows for the simultaneous determination of the individual and interactive effects of many factors that could affect the response function (13).

It can be divided into two steps: one for screening the most effective compounds; and one to optimise their concentration – for example, to support cell growth. The Plackett-Burman design is a two-level multifactorial design based on the rationale known as balanced incomplete blocks. Using this, up to N-1 components can be studied in N experiments, where N must be a multiple of four (14). The two levels tested are usually defined by performing a series of toxicity studies for each individual compound. The doseresponse effect of a given compound on cell viability is then studied, and the upper limit for the screening tests is set at the concentration showing a clear decline in the viability curve.

After finding the most relevant factors that influence cell growth, the next step is to enhance the concentrations of these components in the growth medium. Response surface methodology (RSM) is a powerful experimental tool for seeking the optimum conditions for a multivariable system, and is a favourable technique for optimisation (15). It comprises mathematical and statistical procedures that can be used to study relationships between one or more responses and a number of independent variables, and also generates a mathematical model describing the overall process (16).

The Box-Behnken design is a type of RSM which combines 2k factorials with incomplete block designs. The resulting designs are usually very efficient, as they require few experiments and allow for the determination of combined effects of different factors.

Case Study

In an experiment, CHO S cell growth optimisation was carried out using the chemically-defined medium FreeStyleCHO. Up to eight non-animal-derived compounds were tested as supplements – recombinant insulin (rInsulin), recombinant transferrin (rTransferrin), recombinant albumin (rAlbumin), selenium, tocopherol acetate, synthetic cholesterol, tween 80 and fatty acids – in order to increase maximum cell density. It is generally recognised that the expression of a recombinant protein in CHO cell cultures is directly proportional to the integer of viable cells of the growth curve.

Plackett-Burman initial screening experiments indicated that only three of the supplements (rInsulin, rTransferrin and selenium) had positive effects on cell growth. However, in spite of tween 80 having a positive slope, and therefore an individual positive effect, it was discarded for the next round of optimisation due to its negative interaction with some of the other supplements tested.

The concentration of the three selected components was further optimised by means of a Box-Behnken design. A maximum cell density of 10 x 106 cells/mL in batch mode was achieved for FreeStyleCHO medium supplemented with selenium (1μg/L), rTransferrin (20.2 mg/L) and rInsulin (26.1 mg/L), while only 8 x 106 cells/mL could be achieved with unsupplemented medium.

For HEK 293 cells, two aspects were tested: cell growth as well as efficiency of transient transfection. In general, transient transfection is used at the process development level when relatively small quantities of a given molecule need to be produced rapidly for structural and functional testing, including preclinical trials. Transient transfection in this particular case was performed to produce HIV-1 Gag-GFP virus-like particles (VLPs). The medium selected was FreeStyle, and supplementation with non-animal-derived components included rInsulin, rTransferrin, rAlbumin and a mixture of lipids. Plackett-Burman initial screening experiments indicated that only three of the supplements (rInsulin, rTransferrin and lipid mix) had positive effects.

The concentration of these components was further optimised by means of a Box-Behnken design. Such optimisation resulted in improved HEK 293 cell growth and VLP production for optimal concentrations of rInsulin (19.8mg/L), r-Transferrin (1.6mg/L) and lipid mix (0.9X).

The maximum cell density attained using the optimised culture medium was 5.4 × 106 cells/mL in batch mode – almost double that observed using the unsupplemented medium (2.9 × 106 cells/mL). Best production performance was attained when cells were transfected at mid-log phase (2-3 × 106 cells/mL) with medium exchange at the time of transfection using standard amounts of plasmid DNA and polyethylenimine (17). By using optimised production protocol, VLP titers were increased by 2.4, therefore obtaining 2.8μg of Gag-GFP/mL corresponding to approximately 8.2 × 109 VLPs/mL.

Optimal Conditions

In conclusion, two study cases have outlined an approach to optimise a given chemically-defined commercial cell culture medium by its supplementation with non-animalderived compounds. The use of DoE as a tool to accelerate both the screening of the most efficient compounds and the determination of the corresponding optimal conditions is very effective. For CHO S cells, the optimal conditions were found for FreeStyleCHO medium supplemented with selenium (1μg/L), rTransferrin (20.2mg/L) and rInsulin (26.1mg/L); while for HEK 293 cells, the optimal conditions were found for FreeStyle medium supplemented with rInsulin (19.8mg/L), rTransferrin (1.6mg/L) and lipid mix (0.9X).

References

1. Barnes D and Sato G, Serum-free cell culture: A unifying approach, Cell 22: pp649-655, 1980
2. Merten OW, Development of serum-free media for cell growth and production of viruses/viral vaccines – Safety issues of animal products used in serum-free media, Dev Biol 111: pp233-257, 2002
3. Keenan J, Pearson D and Clynes M, The role of recombinant proteins in the development of serum-free media, Cytotechnology 50: pp49-56, 2006
4. Brunner D et al, Serum-free cell culture: The serum-free media interactive online database, ALTEX 27: pp53-62, 2010
5. Schubert D, Insulin-induced cell-substratum adhesion, Exp Cell Res 124: pp446-451, 1979
6. Mather JP and Sato GH, The growth of mouse melanoma cells in hormone-supplemented, serum-free medium, Exp Cell Res 120: pp191-200, 1979
7. Kovár J and Franek F, Serum-free medium for hybridoma and parental myeloma cell cultivation: A novel composition of growth-supporting substances, Immunol Lett 7: pp339-345, 1984
8. Bretscher MS, The molecules of the cell membrane, Sci Am 253: pp100-108, 1985
9. Nielsen FH, New essential trace elements for the life sciences, Biol Trace Elem Res 26-27: pp599-611, 1990
10. Darfler FJ and Insel PA, Clonal growth of lymphoid cells in serum-free media requires elimination of H2O2 toxicity, J Cell Physiol 115: pp31-36, 1983
11. Farrant J, Newton CA, North ME, Weyman C and Brenner MK, Production of antibody by human B cells under serum-free conditions, J Immunol Methods 68: pp25-34, 1984
12. Francis GL, Albumin and mammalian cell culture: Implications for biotechnology applications, Cytotechnology 62: pp1-16, 2010
13. Castro PM, Hayter PM, Ison AP and Bull T, Application of a statistical design to the optimization of culture medium for recombinant interferon-gamma production by Chinese hamster ovary cells, Appl Microbiol Biotechnol 38: pp84-90, 1992
14. Ahuja SK, Ferreira GM and Moreira R, Application of Plackett- Burman design and response surface methodology to achieve exponential growth for aggregated shipworm bacterium, Biotechnol Bioeng 85: pp666-675, 2004
15. Box GEP et al, Statistics for Experimenters: Design, Innovation, and Discovery, 2nd edition, Wiley, 2005
16. Montgomery DC et al, Response Surface Methodology: Process and Product Optimization Using Designed Experiments, 3rd edition, Wiley, 2009
17. Cervera L et al, Generation of HIV-1 Gag VLPs by transient transfection of HEK 293 suspension cell cultures using an optimized animal-derived component free medium, J Biotechnol 166: pp152-65, 2013




Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Francesc Gňdia is a Professor of Chemical Engineering at Universitat Autňnoma de Barcelona (UAB) where his research activity is focused on biotechnology and biochemical engineering, specifically the culture of mammalian cells in the production of proteins. Previously, he served as Head of the Chemical Engineering Unit at UAB and coordinated the Chemical Engineering degree, and was President of the Spanish Society for Biotechnology. Francesc is author of more than 80 papers, holds 50 patents, and is one of the founders of HEXASCREEN Culture Technologies, which focuses on the development of single-use minibioreactors for screening in biotechnology.
spacer
Francesc Gňdia
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Automated Enzyme Analyzers Streamline Enzyme Assay Applications

SUNNYVALE, Calif. – (September 16, 2021) – Multi-enzyme analysis can now be achieved through a single, fully-automated enzyme analyzer, benefitting industrial enzyme manufacturers and enzyme users in the food, beverage, biopharmaceutical, fuel ethanol and chemical, and solid waste management industries.
More info >>

White Papers

Nasal Drug Delivery with a Focus on Chronic Rhino-Sinusitis

Aptar Pharma

Aptar Pharma have hosted a scientific roundtable on “Nasal drug delivery with a focus on chronic rhino‑sinusitis”. This international scientific forum was held in Paris, France on November 13th 2012. The roundtable was organized to explore and exchange views on the science of various forms of sinusitis and its related unmet medical needs.
More info >>

 

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement